Find the Right Lawyer
Research an Area of Law
Select an area to learn more.
- Asbestos
- Brain Injury
- Car Accidents
- Cerebral Palsy
- Choosing a Personal Injury Attorney
- Defective Products
- Dog Bites
- Elder Abuse
- Medical Malpractice
- Mesothelioma
- Negligence
- Personal Injury
- Personal Injury Damages
- Personal Injury Settlements
- Pharmaceutical Litigation
- Product Liability
- Slip and Fall
- Statute of Limitations
- Tort Law
- Toxic Material
- Workers' Compensation
- Wrongful Death
Not finding what you're looking for?
Advanced Research
Pharmaceutical Litigation, Defective Drugs and Medical Devices
Each year, thousands of people die from or are seriously injured by prescription and over-the-counter drugs they believe to be safe. Patients trust these defective drugs will not harm them because they have been approved by the U.S. Food and Drug Administration or been prescribed by doctors or pharmacists they know and trust. But unfortunately, many of these defective drugs are inadequately tested or have insufficient warnings on their labels. Ultimately, they can lead to serious health ailments, from high blood pressure to acute liver failure.
Please review the list below. If you have been prescribed one of these defective drugs, some of which have been the subject of drug recalls, you may be entitled to collect financial damages, even if you experienced no side effects. A personal injury attorney who specializes in pharmaceutical litigation can help determine if you have a case - even if the defective drug you took is not listed here.
Contact a personal injury attorney in your area to discuss your potential pharmaceutical litigation lawsuit.
The following drugs have been the subject of a drug recall or are suspected of being defective drugs.
COX-2 Inhibitors
VIOXX ®
Classified as a COX-2 inhibitor, VIOXX® ( rofecoxib) is a non-steroidal, anti-inflammatory drug intended to treat menstrual and arthritis pain. However, the drug is believed to do far more harm than good: VIOXX®, believed to be a defective drug, is known to cause heartburn, nausea, diarrhea, upper respiratory tract infection, swelling of the lower extremities, high blood pressure, itching, stomach ulcers or bleeding, fatigue, vomiting, dark urine, and black stools. Additionally, recent studies have also linked VIOXX® to an increased risk of heart attack and stroke. To receive a free case evaluation for your Vioxx® claim, please visit vioxxfyi.com.
On September 30, 2004, VIOXX's manufacturer, Merck CO & Inc. pulled this defective drug from the shelves. The FDA in response issued a public health advisory to warn users of its potential risks.
If you have been affected by VIOXX®, which was recently the subject of a drug recall, consult a personal injury attorney in your area to learn more about your potential pharmaceutical litigation case.
Bextra®
Like VIOXX®, Bextra® is a nonsteroidal anti-inflammatory drug (NSAID) designed to alleviate the symptoms of rheumatoid arthritis, including joint inflammation and swelling. The drug, classified as a COX 2 inhibitor, reportedly prevents the stomach ulcers and gastrointestinal bleeding believed to be caused by other NSAIDs. However, some research shows that like Vioxx®, Bextra® can cause a number of serious side effects, from stomach bleeding to upper respiratory infection. For a free case evaluation of your Bextra® claim, please visit bextrafyi.com.
If you have taken Bextra® and been subsequently harmed, contact a personal injury lawyer today.
Celebrex®
Celebrex® is a non-steroidal, anti-inflammatory COX-2 inhibitor drug intended to treat joint inflammation and arthritis pain - but, like Vioxx®, it has been deemed dangerous: Celebrex® has been linked to at least 10 deaths, 11 cases of gastrointestinal bleeding that required hospitalization, and an increased risk of stomach ulcers. There is also some evidence that taking Celebrex® can increase or double users' risk of blood clots, heart attack, and stroke.
Despite this evidence, the makers of Celebrex® asked the FDA to remove label warnings about stomach ulcers, claiming that medical reviewers did not find any evidence to suggest that Celebrex® was associated with a lower rate of stomach ulcers than traditional NSAIDs. The FDA denied the request, as it found that taking low-dose aspirin (to prevent heart attack) in combination with Celebrex® increased the risk of developing ulcers.
If you have taken Celebrex®, which some experts believe to be a defective drug, and have experienced adverse side effects, you may be entitled to compensation. Consult a personal injury lawyer in your area for more information about pharmaceutical litigation and drug recalls.
Cholesterol Drugs
Crestor®
Crestor® (rosuvastatin) is an HMG-CoA reductase inhibitor drug, or statin, designed to lower cholesterol levels by halting production of a certain enzyme in the liver. The drug has been linked to a slew of serious health problems, ranging from muscle weakness and asthenia to kidney damage and total renal failure. This possibly defective drug is particularly dangerous to pregnant or nursing mothers, although it is not on the list of drug recalls.
If you have been harmed by Crestor®, it is in your best interest to speak to a personal injury attorney in your area about building a pharmaceutical litigation case.
Baycol®
Between 1997 and 2001, Baycol®, a potentially defective statin drug, was commonly prescribed to lower cholesterol by preventing lipid production. Unfortunately, it was also linked to at least 31 deaths in the United States and more than 52 worldwide. Baycol® has also been said to cause rhabdomyolysis, a typically non life-threatening but nonetheless serious muscle ailment that puts undue stress on the kidneys. Symptoms of rhabdomyolysis include fatigue, muscle pain, joint pain, dark urine, nausea, and other discomforts.
Although Baycol®'s manufacturer, Bayer Pharmaceutical, voluntarily discontinued Baycol® in the United States in 2001, you may still be entitled to compensation if you have been harmed by this possibly defective drug. Contact a personal injury lawyer in your area to learn more about this your possible pharmaceutical litigation case, this drug recall, and other drug recalls. To receive a free case evaluation for your Baycol injury, please visit baycolfyi.com.
Erectile Dysfunction Drugs
Viagra® and Cialis®
Viagra® was approved by the FDA in March of 1998 for the treatment of erectile dysfunction (ED) and has since been prescribed to millions of men in the U.S. and around the world. Two months after approval, Pfizer™ issued a letter warning of sudden drops in systemic blood pressure in a majority of patients taking Viagra®. Doctors were advised to take their patients’ cardiac status into account before prescribing the drug.
In November of 1998, new product warning labels were placed on Viagra® bottles in response to the potential dangers associated with its use. Viagra’s® new warning labels mentioned the possibility of heart attack, sudden death due to cardiac complications, hypertension, and priapism, a serious disorder requiring immediate medical attention in which a man develops a painful and prolonged erection.
Side effects are not limited to cardiovascular complications alone. A study completed in January 2006 suggested that men with a history of high blood pressure and heart attack who take Viagra® or Cialis® are ten times more likely to suffer from a vision threatening condition called NAION. Prior to this report, the Journal of Neuro-Opthalmology published the results of a study in which seven men experienced NAION within three days of taking Viagra® and other ED medications. According to a subsequent CBS News report, over 8,000 ED patients claimed to have experienced vision problems while taking Viagra®, Cialis® or other related medications.
If you have been adversely affected by Viagra® or Cialis®, you may be eligible to receive compensation for your damages. Contact a personal injury attorney in your area today to discuss the specific circumstances surrounding your case.
Defective Medical Devices
Medtronic Marquis® Defibrillators
Allograft Implants
Allograft implants are used in numerous types of reconstructive surgeries that require extra bone, skin, cartilage, tendons and connective tissue. The implants, which are harvested from donors (usually cadavers at time of death), allow surgeries to be performed without extracting tissue from the patient.
In recent years, it has been uncovered that the top U.S. tissue transplant companies have been more focused on profit than on safety or ethics. Cryolife, the leading provider of transplanted human tissue, was cited by the FDA for regulatory violations due to negligence that could have caused allograft contamination. In 2002, Cryolife was ordered by the FDA to recall and destroy all of its human tissue products. Although the company’s ability to distribute allograft products has since been reinstated, contaminated tissue was linked to several deaths and many medical complications.
In the fall of 2005, Biomedical Tissue Services (BTS) was required to recall its allograft products due to its involvement in the theft and distribution of bone and tissue products. The company not only stole the allografts from non-donor cadavers, but it also failed to screen the illegally harvested bone and tissue for disease, subjecting unknowing recipients to infections and other serious health problems.
If you feel that you or a loved one might have received contaminated allograft implants, contact a personal injury attorney today.
Guidant Defibrillators
Like Medtronic defibrillators, Guidant’s implantable cardioverter defibrillators (ICD) are supposed to help prevent cardiac deaths; however, product flaws have caused many of the ICDs to malfunction. These defective defibrillators have failed at least 45 times and have been linked to at least two wrongful deaths. Guidant recalled about 50,000 ICDs due to a short-circuiting malfunction, and the company announced that another 45,000 devices may have faulty switches.
An independent research panel appointed by Guidant found that the engineers at the company were making medical decisions without consulting doctors. It was also discovered that Guidant did not alert physicians of possible risks associated with the defibrillators.
If you have been injured by a defective Guidant defibrillator, contact a personal injury lawyer today to discuss your legal options and the specific circumstances of your case.
Medtronic Marquis® Family of Defibrillators
Implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) are implanted in patients who are at high risk for sudden cardiac death. The devices monitor the heart for irregular heartbeat or arrhythmias. When an irregularity occurs, the defibrillators deliver an appropriate shock to prevent a heart attack. The Medtronic Marquis® family of ICD and CRT-D devices with batteries manufactured prior to December 2003 may be prone to rapid battery depletion due to a specific internal battery short mechanism. If the defibrillator’s battery fails, the results could be deadly.
In February 2005, Medtronic issued a statement that 87,000 units were sold with the defective batteries. The defective defibrillators include Marquis® VR (model 7230) and DR (model 7274), Maximo® VR (model 7278), InSync I /II /III Marquis™, and InSync III Project™ (models 7277, 7289).
If you or a loved one has been adversely affected by any of the defective Medtronic defibrillators, contact a personal injury attorney for information about how you can join a class action lawsuit against this manufacturer.
Medtronic Sigma™ Series Pacemakers
The Medtronic Sigma™ series pacemakers are surgically implanted and attached to the heart by wires. These small, battery-powered devices are designed to monitor the electrical impulses of the heart and ensure that a normal heart rate is maintained. However, it has been discovered that some of the Medtronic Sigma™ series pacemakers have a faulty connection, allowing for a separation of the wiring from the hybrid circuit. Such a disconnection of the wires will cause the pacemaker to fail and may put patients’ lives in danger. The surgery to replace these devices also creates unnecessary health risks since the likelihood of post-surgical infection is higher for patients with weakened immune systems. If an infection does occur, then all of the hardware has to be removed in a potentially dangerous procedure.
If you have a pacemaker from the Medtronic Sigma™ series, consult a personal injury attorney to learn more about filing a product liability lawsuit.
Ortho Evra® Patch
The Ortho Evra® patch, manufactured by Ortho-McNeil Pharmaceutical, Inc., is a birth control patch that was approved by the FDA in November 2001. The adhesive patch has become the most popular form of prescribed birth control in the United States, used by over five million women. Marketed to doctors and their patients as safe and “effective as the pill but even simpler,” the Ortho Evra® patch works in the same way as oral birth control pills: they both release a constant supply of hormones in order to prevent ovulation and therefore pregnancy. However, the Ortho Evra® patch releases 60 percent more estrogen into a woman’s bloodstream than does the average birth control pill.
The patch has become associated with serious side effects including blood clots, stroke, heart attack, coma, and death. The FDA reports that at least 17 women between the ages of 17 and 30 have suffered serious and fatal side effects since 2002. Ortho-McNeil began warning the public about the high dose of estrogen and related health risks in November 2005.
The Ortho Evra® patch is currently the focus of lawsuits filed on the behalf of victims who have experienced serious injury or death after using it. If you or someone you love has suffered serious side effects while using the Ortho Evra® patch, please contact a personal injury lawyer today.
Sulzer Hip
The Sulzer Inter-Op™ Acetabular Shell is an orthopedic implant used in hip replacement surgeries. Unlike traditional implants that must be screwed or cemented into place, the Inter-Op™ shell was designed to allow the bone to bond naturally with the device. During the manufacturing of the Sulzer hip joint replacement, lubricant residue was left on the device. This residue hindered the shell from properly fusing with the bone, causing many patients to suffer from extreme groin pain and the inability to bear weight on their leg.
In December of 2000, Sulzer voluntarily recalled approximately 40,000 units of its Inter-Op™ Acetabular Shell, of which about 26,000 had already been implanted in patients. In May 2002, a U.S. district court approved a class action settlement against Sulzer regarding the defective products.
If a defective Inter-Op™ shell was used as part of your hip replacement surgery, contact a personal injury attorney to learn more about your potential case.
Atypical Anti-Psychotics
Risperdal®
Johnson & Johnson’s Risperdal®, also known as Risperidone, belongs to a class of medications called “atypical anti-psychotics.” Risperdal® was approved by the FDA in 2003 as a treatment for bipolar disorder, schizophrenia, and other psychotic illnesses that are characterized by symptoms of mania, hallucinations, and/or anxiety. These symptoms are thought to be caused by chemical imbalances in the brain; Risperdal® seems to readjust the balance of these chemicals, helping to control symptoms. Risperdal® was intended to have fewer side effects than older anti-psychotic drugs, and millions of adults and children have used it.
However, a 2003 study reported that there were 49 percent more cases of diabetes among patients taking Risperdal® than among patients using older anti-psychotic drugs. Risperdal® has been linked not only to type 2 diabetes, but to hyperglycemia, other blood sugar disorders, and pancreatitis—a dangerous inflammation of the pancreas. After the study, the FDA required Risperdal® to carry a new warning label that recommends its users be monitored for blood sugar abnormalities.
If you have contracted diabetes, other blood sugar disorders, or pancreatitis after using Risperdal®, contact a personal injury lawyer to discuss a possible pharmaceutical litigation claim.
Seroquel®
Seroquel®, or quetiapine fumarate, belongs to a class of drugs known as “atypical anti-psychotics.” AstraZeneca’s Seroquel® is used to treat schizophrenia, bipolar disorder, and a wide range of other psychotic illnesses that share such symptoms as delusion, thought disorders, hallucinations, and social withdrawal. Millions of patients have taken Seroquel® since the drug was approved in 1997.
Data from a 2003 study suggested that there were 3.34 times as many cases of diabetes among Seroquel® patients than among patients taking older anti-psychotic medication. Seroquel® is linked not only to type 2 diabetes, but to hyperglycemia, other blood sugar disorders, and pancreatitis – an inflammation of the pancreas. After the study, the FDA issued a MedWatch safety alert about Seroquel®.
If you or a loved one has developed diabetes, any other blood sugar disorders, or pancreatitis after using Seroquel®, please contact a personal injury lawyer to discuss your pharmaceutical litigation case.
ADHD Drugs
Adderall®
Adderall®, the brand name for amphetamine-dextroamphetamine, was approved in 1996 for the treatment of attention deficit hyperactivity disorder (ADHD). The Federal Food and Drug Administration (FDA) released a report in February 2006, describing a potential link between Adderall® and the occurrence of heart attacks, high blood pressure and other cardiovascular complications that may result in sudden death. The FDA report cites 51 deaths that may have resulted from the use of Adderall® and Ritalin®, two drugs widely prescribed to treat ADHD.
Many reputable medical experts believe that Adderall® and Ritalin have been prescribed far too frequently as a treatment for behavioral problems in school-aged children. Because Adderall® is highly addictive and lends itself easily to abuse, these critics argue that the benefits of the drug are often outweighed by its risks and that, therefore, its prescription should be limited to very specific cases of ADHD.
If you or your children have been harmed by the addictive and potentially dangerous drug Adderall®, you may be eligible for compensation. Contact a personal injury lawyer with pharmaceutical litigation experience in your area today to learn more about your legal options.
Ritalin®
Ritalin®, also known as methylphenidate, has been widely prescribed to patients of all ages to combat an array of behavioral and attention deficit related disorders. A February 2006 FDA report indicates that Ritalin® may pose serious health risks including heart attack, stroke, high blood pressure, and other potentially fatal cardiovascular problems. The report finds that 51 deaths may be linked to the use of Ritalin® and Aderall®.
The FDA has been hesitant to suggest a definitive link between Ritalin® use and sudden death, but regulators have been warned to closely monitor the use of all ADHD drugs for potentially fatal side-effects.
If you or a loved one has taken Ritalin® and feel you may be at risk, contact an experienced and skilled pharmaceutical litigation attorney in your area to learn more about your possible right to compensation under the law.
Other Defective or Dangerous Drugs
Accutane®
Once the most often-prescribed acne medication on the U.S. market, Accutane® is now considered a defective drug, having been associated with depression, suicide, psychosis, and birth defects, namely mental retardation and physical deformities. Accutane® is still available by prescription, although women who are at risk for becoming pregnant while on the drug must sign a waiver that informs them of the risk before they are given a prescription.
If you have been harmed by the defective drug Accutane®, you may be eligible for compensation. Consult a personal injury attorney in your area to find out how to file a pharmaceutical litigation claim.
Fen-Phen
A combination of fenfluramine (Podimin), phentermine (Ionamin), and dexfenfluramine, Fen-Phen, a defective drug, was used weight loss drug used by at least 6 million Americans until it was recalled in 1997 after reports linked it to heart valve disease, primary pulmonary hypertension (PHH), heart failure, lung failure, aortic and mitral heart valve damage (regurgitation), and other serous conditions.
If you have used the defective drug Fen-Phen, you may be eligible for compensation. Contact a personal injury lawyer with pharmaceutical litigation experience in your area today to learn more about your particular case and other recent drug recalls.
Ketek®
Ketek®, or telithromycin, is an antibiotic commonly used to treat an array of respiratory infections, including pneumonia, bronchitis, and sinus infections. According to the FDA, three people have suffered severe liver damage as a result of taking Ketek®. Each of these people developed jaundice, a yellowing of the skin and eyes, and produced abnormal blood tests consistent with diminishing liver function. All three had been in good health and had not been taking any other medications. Of the three, two have died.
If you have been harmed by Ketek®, it is in your best interest to speak to a personal injury attorney in your area to learn about your legal rights and options.
Mirapex®
Mirapex® is a drug prescribed to alleviate some of the symptoms associated with Parkinson’s disease. However, a Mayo Clinic study released in July of 2005 suggested a possible link between the drug and compulsive gambling disorder. This study built upon past studies that have found a connection between dopamine agonist, the generic name for Mirapex®, and a general rise in compulsive disorders.
If you have been adversely affected by the potentially defective drug Mirapex®, you may be entitled to compensation for your damages. Contact a personal injury attorney in your area today for more information about your potential case.
Neurontin®
The makers of Neurontin®, an epilepsy-treatment drug, are currently facing an anti-trust lawsuit for extending their monopoly over the main ingredients in Neurontin® well past the expiration of their patents. By preventing others from having access to the ingredients, the defendants - Pfizer, Inc. and the Warner-Lambert Company - cost users millions that they could have saved had there been a generic alternative available. The defendants, accused of violating the Sherman Anti-Trust Act, are also believed to have falsely claimed copyright infringement to prevent competitors from profiting.
Neurontin® users may be entitled to some damages. If you believe you qualify, contact a personal injury attorney in your area today for more information about pharmaceutical litigation.
For more information about defective drugs, a defective drug you have taken, or the steps of pharmaceutical litigation, find and ask a lawyer in your area today.
Oxycontin®
Oxycontin® most recently made headlines when radio announcer Rush Limbaugh admitted his addiction to the powerful, heroin-like painkiller in 2003. The opiate, which is highly addictive for both legitimate and illegitimate users, is covered by most insurance plans, thereby making it significantly cheaper than illegal drugs- so cheap, in fact, that Oxycontin® has been nicknamed “hillbilly heroin” and “poor man' s heroin” on the street.
Oxycontin®, which many consider to be a defective drug, is also heavily marketed by its manufacturer, Purdue Pharma. Its accessibility, affordability, and extremely addictiveness make Oxycontin® inherently dangerous. It has been associated with more than 100 deaths, most of which involve mixing the drug with alcohol. Critics blame Purdue Pharma for these tragedies, claiming that the corporation failed to sufficiently warn doctors and patients of 1) how addictive Oxycontin® truly is and 2) that mixing it with alcohol could be so deadly.
Oxycontin® has yet to become a subject of a drug recall.
If you have become addicted to the potentially defective drug Oxycontin and if you obtained it with a prescription, you may be entitled to compensation. Refer to a personal injury lawyer in your area to find out more information about pharmaceutical litigation.
Paxil®
Paxil® is an antidepressant drug belonging to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). Paxil® is believed to be very addictive, and many users report severe withdrawal symptoms after discontinuing use. Some experts even link Paxil® to an increased suicide risk.
GlaxoSmithKline Corporation, the manufacturer of Paxil®, has been accused of misleading the public and the medical profession by downplaying side effects of the drug. In response, many victims have banded together and filed class action lawsuits against Glaxo Smithkline Corporation.
If you have been adversely affected by the potentially defective drug Paxil®, you may be able to pursue pharmaceutical litigation. Contact a personal injury attorney in your area today for more information about your potential case as well as recent drug recalls.
Prempro®
A hormone replacement therapy (HRT) drug prescribed to treat menopause symptoms, Prempro® was recently a subject of a drug recall. It was pulled from shelves in 2002 after the Women' s Health Initiative Study found that it increased women' s risk of stroke by 41 percent, cardiovascular disease by 29 percent, and breast cancer by 26 percent. Warnings from the American Heart Association and the Journal of the American Medical Association also prompted the recall.
If you have taken the defective drug Prempro®, your health could be at risk. Contact a personal injury attorney in your area today to discuss your pharmaceutical litigation case.
Rezulin®
Rezulin® is an anti-hyperglycemic drug used to treat Type II diabetes. While it is not an insulin substitute, Rezulin® helps the body better use the insulin it does produce. But this isn't without consequence - Rezulin® is rather dangerous for many patients. In fact, since its approval by the FDA in 1997 (the same year Great Britain withdrew the drug from its market), Rezulin®, now believed to be a defective drug, has consistently been linked to heart failure, thickening in the left ventricular wall of the heart, severe liver damage, liver failure, an increased demand for liver treatments, and at least 63 deaths. Rezulin® was finally yanked from shelves in March 2000, but for many, the damage was already done.
If you have been harmed by Rezulin®, it is in your best interest to meet with a personal injury attorney in your are a and learn more about what pharmaceutical litigation.
Tequin®
Tequin® (gatifloxacin) marketed by Bristol-Myers Squibb Company is a prescription antibiotic which has been associated with cases of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar), conditions especially dangerous to those with diabetes.
Tequin® is an antibacterial medication administered either in tablet form or as an injection to treat infectious diseases including pneumonia, bronchitis, infections of the urinary tract, kidneys, and skin, as well as a form of gonorrhea. Tequin® received Food and Drug Administration (FDA) approval in 1999. On February 16, 2006, FDA advised the public that Bristol-Myers Squibb was labeling Tequin® to alert medical professionals to the possible risk of hypoglycemia, hyperglycemia, and related complications, and to the fact the fatalities may be related to the use of Tequin®.
If you or someone you know has suffered kidney problems, heart attacks, stroke, or other serious medical conditions after taking Tequin®, please contact a personal injury lawyer in your area to find out if you may be eligible for compensation and for assistance filing a pharmaceutical litigation claim.
Trasylol®
Trasylol® is an injectable drug also known as aprotonin; it is used during cardiopulmonary bypass surgery in order to inhibit inflammation and prevent blood loss during the operation. Produced by Bayer, Trasylol® was approved in 1993 and marketed to be a safe and vital component of bypass and other heart surgeries. Millions of patients have had the drug administered to them during their surgeries.
In January 2006, an article in The New England Journal of Medicine stated that Trasylol® can factor into life-threatening, post-surgery complications. The use of Trasylol® increased the risk of heart attack by 48 percent, heart failure by 109 percent, and stroke by 181 percent, according to a study of 4400 patients. They also found a significant risk of renal (kidney) failure and damage to brain tissue. The FDA issued a public health advisory in February 2006, stating that they will conduct a safety evaluation of Trasylol® to further examine its risks.
If you experienced kidney, heart, or central nervous problems after your cardiopulmonary bypass surgery, you may have suffered adverse effects from the use of Trasylol®. Contact a personal injury lawyer to discuss your potential claim.
Zyprexa®
In 1996, the FDA approved Zyprexa® as a treatment for bipolar disorder, schizophrenia, and other psychotic illnesses. It effectively controls the hallucinations, delusions, withdrawal, and various symptoms typically associated with such conditions - but not without a price. In late 2001, researchers linked Zyprexa®, now deemed a potentially defective drug, to diabetes, diabetic ketoacidosis, hyperglycemia, pancreatitis, and diabetes-induced heart attack or coma. Patients under age 54 - especially adolescents - are at highest risk. For a free case evaluation for your Zyprexa® claim, please visit zyprexadruginfo.com.
Zyprexa® has not yet been the subject of a drug recall.
If you have taken the drug Zyprexa® and experienced any of the aforementioned side effects, you may be entitled to compensation. Contact a personal injury lawyer in your area today to learn more about pharmaceutical litigation.